Nous contacter

Tel. +33(0)2 53 00 91 22

Mob. +33(0)6 83 82 26 78

Mail: contact@labcom-risca.com

  • LinkedIn Social Icône
  • Facebook
  • Twitter
  • YouTube

Qui sommes-nous ?

Le laboratoire SPHERE (methodS for Patients-centered outcomes and HEalth REsearch, INSERM UMR 1246, Université de NantesUniversité de Tours) et la société IDBC (groupe A2com) ont décidé de créer ensemble le Laboratoire Commun RISCA (Research in Informatics and Statistics for Cohort-based Analyses)

 

s'INSCRIRE à NOTRE NEWSLETTER?

The EKITE cohort

Objectives

The EKiTE (Epidemiology in Kidney Transplantation - a European validated database) aims to built a network with three main transplantation centres in Europe (Barcelone, Spain;  Oslo, Norway; Leuven, Belgium) and the French DIVAT Cohort to set up a European database of kidney transplant patients with validated data quality. This European database will aid to:
  • Provide an international validity to existing clinical research methods for kidney transplant patients.
  • Perform epidemiological studies on rare patient profiles or infrequent complications due to the large cohort size.
  • Better understand the evolution of kidney transplant patients in Europe and compare this to the information that is available from the North-American and Australian registries.
  • Support the European guidelines for management of kidney transplant patients (ERBP, European Renal Best Practice).
Magali Giral
Professor in Nephrology

magali.giral@chu-nantes.fr

Tél : +33 (0) 2 40 08 74 43

In charge of clinical investigation unit - Institut de Transplantation Urologie Néphrologie du CHU de Nantes. UMR 1064 CRTI « Center for Research in Transplantation and Immunology».

Department of Nephrology and Renal Transplantation, University Hospitals, Oslo, Norway.

Anders Asberg
Professor in Nephrology
Maarten Naessens
Professor in Nephrology

Department of Nephrology and Renal Transplantation, University Hospitals, Leuven, Belgium.

Oriol Bestard
Professor in Nephrology

Department of Nephrology and Renal Transplantation, Bellvitge University Hospitals, Barcelona, Spain.

Team

Kidney transplantation is considered the treatment of choice for people with end-stage kidney failure, because quality of life and survival are often better than in people who are treated with dialysis. However, in practice the possibility to transplant kidneys is limited, due to a shortage of available organs. It is therefore essential to make kidney transplantations as efficient as possible. 

Home > Presentation > Ekite cohort